Moreover, recent studies suggested that some carbazole-based compounds are valuable anti-AD drug candidates, since they are able to inhibit both AChE and BChE activity [45] as well as AChE- and self-induced Aβ aggregation [46]. This evidence concerns the gene BCHE and Alzheimer disease.